Alzheimer's & Cognition
Conference Coverage
Mid-life cardiovascular risk factors set stage for later-life dementia
HOUSTON - Diabetes conferred the greatest dementia risk, nearly doubling the chance of dementia.
From the Journals
Testosterone Trials’ cardiac, cognitive results disappoint
Testosterone treatment may have beneficial effects on unexplained anemia or bone density, but may increase coronary artery plaque and offer no...
Feature
Proposed Alzheimer’s classification system relies solely on biomarkers
A proposed Alzheimer’s disease classification system relies on the presence or absence of known biomarkers.
From the Journals
Early mild cognitive impairment in Parkinson’s leads to dementia in more than 40%
Developing persistent mild cognitive impairment soon after being diagnosed with Parkinson’s disease significantly increased the risk of subsequent...
Savvy Psychopharmacology
Ruling out delirium: Therapeutic principles of withdrawing and changing medications
Ms. M, age 71, was diagnosed with Alzheimer’s disease several months ago and her clinical presentation and Mini-Mental Status Exam score of 22...
Cases That Test Your Skills
Worsening agitation and hallucinations: Could it be PTSD?
Mr. G, age 57, presents with confusion, hallucinations, and agitation. He has a history of PTSD, depression, anxiety, and lung cancer. What could...
Conference Coverage
Ladostigil advances to phase III after hints of slowing brain atrophy in MCI patients
SAN DIEGO – Ladostigil, a drug that combines molecular characteristics of rivastigmine and rasagiline, was associated with modest memory...
Conference Coverage
Phase I results move Alzheimer’s candidate drug aducanumab into phase III trials
SAN DIEGO
Conference Coverage
Sigma-1 agonist presses forward after positive results in small Alzheimer’s trial
SAN DIEGO
From the Journals
Statins protect against Alzheimer’s in most patients
Statins taken to reduce cholesterol also protect most patients against Alzheimer’s disease, but the decrease in risk varies across different...
From the Journals
Two-test sequence identifies sporadic Creutzfeldt-Jakob with 100% sensitivity, specificity
The sequential use of two diagnostic tests – one assessing cerebrospinal fluid and the other assessing nasal swabs – identifies sporadic...